Form 10-Q Co-Diagnostics, Inc. For: Jun 30
Co-Diagnostics, Inc. (CODX)
US:NASDAQ Investor Relations:
ir.codiagnostics.com/investor-relations
Company Research
Source: SEC EDGAR
Impact Snapshot
Event Time:
CODX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CODX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CODX alerts
High impacting Co-Diagnostics, Inc. news events
Weekly update
A roundup of the hottest topics
CODX
News
- Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and JapanPR Newswire
- Applied DNA stock jumps amid U.S. government mpox update Sep. 06, 2024 3:45 PM ET By: Val Brickates Kennedy , SA News Editor [Seeking Alpha]Seeking Alpha
- Co-Diagnostics, Inc. Completes Updated Clade Ib Analysis of 2-Gene Mpox RUO TestPR Newswire
- Co-Diagnostics, Inc. to Present at 16th Next Generation Dx Summit in Washington, D.C.PR Newswire
- Co-Diagnostics, Inc. (NASDAQ: CODX) had its price target lowered by analysts at HC Wainwright from $2.00 to $1.50. They now have a "neutral" rating on the stock.MarketBeat
CODX
Earnings
- 8/8/24 - Beat
CODX
Sec Filings
- 8/30/24 - Form 8-K
- 8/8/24 - Form 8-K
- 7/16/24 - Form DEF
- CODX's page on the SEC website